Purobien Lifesciences has committed to deliver the absolute highest-quality product to every client, on time and at an unsurpassed value. We are equipped with a highly accomplished F&D facility managed by knowledgeable and dedicated staff; assuring product quality assessment during product shelf life. Our F & D team, who monitor the batch with Pilot facility before commercialization. Our efforts are supported by a well-equipped Quality Control Laboratory managed as per GLP standards.
F&D Team working on the following directions so that we could serve better quality, new drug and technology at affordable price.
Odour less & Taste Masked Oral Medicine: Our Team is working on the oral administration of bitter drugs, especially for paediatric patients. Several oral pharmaceuticals have unpleasant, bitter‐tasting components. So, any pharmaceutical formulation with a pleasing taste would definitely be preferred over a competitor's product and would translate into better compliance and more business and profits for the clients.
Effervescent Medicine: Effervescent tablets are designed to break in contact with liquid such as water or juice, often causing the tablet to dissolve into a solution. This makes effervescent tablets the preferred choice of many, including people who are taking tablets medicinally as well as a dietary supplement.
Chewable Medicine: Chewable formulations are an oral dosage form intended to be chewed and then swallowed by the patient rather than swallowed whole. Our team worked on this formulation and still is working on its smoothness and soothing so that it could be easily chewed and swallowed.
Highly Hygroscopic Drugs : Hygroscopicity is a physicochemical property and it can be described as the ability of a material to take up moisture from surrounding atmosphere. Often, this property is measured at a constant temperature with variations in relative humidity (RH). After developed stable Amoxiclav formulations, now our F&D Team is working on other Highly hygroscopic drugs in the Pharmaceuticals and Nutraceuticals segments.